azauridine has been researched along with Aphasia in 1 studies
Azauridine: A triazine nucleoside used as an antineoplastic antimetabolite. It interferes with pyrimidine biosynthesis thereby preventing formation of cellular nucleic acids. As the triacetate, it is also effective as an antipsoriatic.
Aphasia: A cognitive disorder marked by an impaired ability to comprehend or express language in its written or spoken form. This condition is caused by diseases which affect the language areas of the dominant hemisphere. Clinical features are used to classify the various subtypes of this condition. General categories include receptive, expressive, and mixed forms of aphasia.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dantzig, PI | 1 |
| McEvoy, B | 1 |
| Mauro, J | 1 |
| Rayhanzadeh, S | 1 |
1 trial available for azauridine and Aphasia
| Article | Year |
|---|---|
Low dose azaribine in the treatment of psoriasis.
Topics: Adult; Aged; Anemia; Aphasia; Arthritis; Azauridine; Clinical Trials as Topic; Coma; Headache; Human | 1974 |